Issue Date: October 21, 2013 | Web Date: October 17, 2013
Venture Philanthropy Backs Diabetes Research Start-ups
Patient advocacy groups are continuing to push the boundaries of venture philanthropy, which enables them to invest in for-profit firms in order to reach their charitable goals. JDRF, a type 1 diabetes-focused nonprofit, and life sciences development firm PureTech Ventures will launch T1D Innovations, a financial vehicle for the creation of drug discovery companies that target type 1 diabetes.
In recent years, many disease advocacy groups have moved . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society